Press Release: CDx : Advancing Precision in Barrett's Esophagus and Dysplasia Diagnoses: WATS3D Study Demonstrates Exceptional Consensus Among Pathologists
/PRNewswire/ -- CDx Diagnostics, Inc., developer of the WATS3D AI platform for the detection and surveillance of Barrett's esophagus (BE) and dysplasia, today...
Read full article »
CDx Diagnostics is a New York-based AI-assisted diagnostic platform that provides synthesizes computer imaging, molecular biology and 3D cytopathology to detect cancer.
Read more